Home›Stock Screener›Infinium Pharmachem

Infinium Pharmachem Share Price Today | Stock Price & Infinium Pharmachem Share Screener

INFINIUM Pharmaceuticals & Biotechnology

Track the current Infinium Pharmachem share price and stock price live with TickJournal's free stock screener. Track Infinium Pharmachem market cap to gauge the company's total market size. Use the Infinium Pharmachem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Infinium Pharmachem opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Infinium Pharmachem Market Cap ₹491.49 Cr.
INFINIUM P/E Ratio (TTM) -
Infinium Pharmachem P/B Ratio 3.97
EPS (TTM) ₹7.80
Dividend Yield -
Debt to Equity 0.32
INFINIUM 52 Week High -
Infinium Pharmachem 52 Week Low -
Operating Margin -
Profit Margin -
INFINIUM Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹175.00
Total Equity ₹139.00

Infinium Pharmachem Share Price Chart

Track the current stock price of Infinium Pharmachem with an interactive chart. Analyse INFINIUM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Infinium Pharmachem stock quote in one place.

Infinium Pharmachem Company Profile - Fundamental Screener

Screen Infinium Pharmachem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INFINIUM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE0MRE01011.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE0MRE01011

Infinium Pharmachem Balance Sheet Screener

Screen INFINIUM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹175, down from ₹198 in 2025.

Latest statistics put total assets at ₹175 and shareholder funds at ₹139, with a leverage ratio of 0.32.

Item 2026 2025 2024 2023 2022 2021 2020

Assets

Total Assets 175 198 86 71 59 34 22
Current Assets 0 0 0 0 0 0 0
Fixed Assets 24 24 20 19 4 5 4

Liabilities

Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 8 10 8 10 14 6 6
Non-Current Liabilities 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 139 125 60 24 14 7 4
Share Capital 16 16 14 5 1 1 1
Reserves & Surplus 106 94 45 18 12 6 3

Infinium Pharmachem Income Statement Screener - Profit & Revenue Analysis

Screen Infinium Pharmachem income statement and profit fundamentals. Analyze INFINIUM quarterly results. Infinium Pharmachem reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹192 and net profit of ₹14.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Revenue and Expenses

Revenue 0 192 158 137 116 100 71 39
Expenses 0 168 139 117 98 89 66 36

Operating Costs and Margins

EBITDA 0 24 19 20 17 11 6 3
Operating Profit % 0.00% 11.00% 11.00% 14.00% 14.00% 10.00% 7.00% 6.00%
Depreciation 0 3 3 3 1 1 1 1
Interest 0 3 4 2 3 2 1 1

Profit and Earnings

Profit Before Tax 0 18 12 15 13 9 4 1
Tax 0 4 4 4 3 2 1 0
Net Profit 0 14 8 12 10 7 3 1
EPS 0.00 7.80 5.60 8.12 6.82 60.07 26.80 9.19

Infinium Pharmachem Cash Flow Screener - Liquidity Fundamentals

Screen INFINIUM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹34, and net cash flow was an outflow of ₹5.

Over the same period, investing activities used ₹7 and financing activities used ₹32.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Cash from Operations and Investing

Operating Activities 34 -29 -13 9 12 7 3
Investing Activities -7 -27 -4 -5 -7 -5 -1

Financing and Net Cash

Financing Activities -32 79 23 -3 -2 -1 -1
Net Cash Flow -5 23 6 1 4 1 1

Infinium Pharmachem Shareholding Pattern Screener

See Infinium Pharmachem shareholding pattern with promoter, FII, and DII holdings. Check Infinium Pharmachem promoter holding and ownership changes for INFINIUM on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 64.91%, foreign institutions 0.00%, domestic institutions 0.22% and the public 31.96%, spread across 1,061 shareholders.

The shareholder count was 1,061 in 2026-Mar, compared with 1,086 in 2026-Sept.

Item 2026-Mar 2026-Sept 2025-Mar 2025-Sept 2024-Mar 2024-Sept 2024-Nov 2023-Feb

Promoter Holding

Promoter Holding 64.91% 64.91% 65.24% 59.91% 73.05% 73.05% 65.24% 100.00%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.22% 0.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 31.96% 32.04% 32.00% 37.21% 23.85% 23.97% 32.05% 0.00%
Other Holding 2.91% 2.82% 2.76% 2.88% 3.10% 2.98% 2.71% 0.00%
Shareholder Count 1,061 1,086 958 1,052 771 947 998 17

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Infinium Pharmachem. Infinium Pharmachem dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Infinium Pharmachem.

Infinium Pharmachem Stock Index Membership - Nifty & Sensex

See which indices include Infinium Pharmachem stock. Check INFINIUM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Infinium Pharmachem is not part of any tracked indices.
Only major market indices are tracked in our system.

Infinium Pharmachem Market Events Screener - Corporate Actions

Get Infinium Pharmachem corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Infinium Pharmachem stock events that may affect INFINIUM share price, along with derivatives, futures and options activity and sector gainers.

10 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 6, 2026, with a record date of November 6, 2026.

It is followed by Quarterly Result Announcement dated May 29, 2026 and Quarterly Result Announcement dated November 13, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-11-06 2026-11-06 Quarterly Result Announcement NA -5.11%
2026-05-29 2026-05-29 Quarterly Result Announcement NA 1.43%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -1.29%
2025-08-21 2025-08-21 Quarterly Result Announcement NA 6.05%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 12.70%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 2.10%
2024-10-23 2024-10-23 Extraordinary General Meeting NA -8.11%
2024-09-28 2024-09-28 Annual General Meeting NA 71.56%
2024-07-06 2024-07-06 Extraordinary General Meeting NA 2.78%
2023-09-13 2023-09-13 Bonus 1:1 -1.11%

Infinium Pharmachem Competitors Screener - Peer Stocks Comparison

Screen INFINIUM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,795 40.80 61,674 12.69% 11,565 60.46
Divis Laboratories 296,674 87.70 11,067 13.95% 2,568 68.76
Torrent Pharmaceuticals 178,450 84.70 13,886 20.34% 2,138 47.23
Laurus Labs 126,968 94.90 6,868 22.01% 890 57.04
Zydus Life Science 119,850 27.90 27,658 17.64% 5,026 55.91
Dr Reddys Laboratories 116,071 42.00 35,059 3.90% 4,158 71.26
Cipla 115,217 39.20 29,045 2.24% 3,870 53.06
Mankind Pharma 108,908 47.50 14,636 14.85% 1,938 61.37
Aurobindo Pharma 104,155 25.90 34,145 5.56% 3,503 60.39
Lupin 89,588 17.10 29,039 26.75% 5,356 39.39

Infinium Pharmachem Company Announcements - News & Reports Screener

Screen INFINIUM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 3.97. Market capitalisation stands at ₹491.49 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 20, 2026. This page covers 7 balance sheet periods, 8 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.